MedTrace Logo

Effect of Single Rinsing With Three Different Types of Mouthwash on VSC Levels in Morning Breath

NCT04279106 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2020-02-20

No results posted yet for this study

Summary

Morning bad breath (MBB) is often an enduring upset; this double blind, crossover, randomized study aimed to evaluate the bad breath-suppressing of 3 commercially available mouth rinses (Mentadent Professional® 0.05%chlorhexidine (MPc), Meridol® Halitosis (MH) and CB12®) and a placebo on morning halitosis during a washout period of 1 week.

Conditions

  • Halitosis

Interventions

PROCEDURE

0.05%chlorhexidine mouthwash

All subjects were instructed to rinse once a day, in the morning, with 15 ml solution for 60 seconds, after which they expectorated. Subsequent rinsing with water was not allowed.

PROCEDURE

0.05% sodium fluoride mouthwash

All subjects were instructed to rinse once a day, in the morning, with 15 ml solution for 60 seconds, after which they expectorated. Subsequent rinsing with water was not allowed.

PROCEDURE

alcohol free essential oils mouthwash

All subjects were instructed to rinse once a day, in the morning, with 15 ml solution for 60 seconds, after which they expectorated. Subsequent rinsing with water was not allowed.

PROCEDURE

Placebo

All subjects were instructed to rinse once a day, in the morning, with 15 ml solution for 60 seconds, after which they expectorated. Subsequent rinsing with water was not allowed.

Sponsors & Collaborators

  • University of L'Aquila

    lead OTHER

Principal Investigators

  • Giuseppe Marzo, DMD · University of L'Aquila

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-09-03
Primary Completion
2019-12-10
Completion
2020-01-16

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04279106 on ClinicalTrials.gov